Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Plan - Growth

Q: How often is Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Plan portfolio data updated?

Portfolio holdings for Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Plan are updated monthly. SEBI mandates all AMCs to disclose their complete portfolio within 10 days of each month end. RightAdvise sources this data directly from official AMFI portfolio disclosures.

Equity Data as of Apr 2026 Comparing Mar 2026 → Apr 2026

Share: WhatsApp X

Stocks Held

Apr 2026

Equity Holdings

₹121.44 Cr

Equity only, excl. debt & cash

Top 5 Weight

33.3%

Moderate

Top 10 Weight

51.3%

Moderate

Changes

0 new · 0 exits

Top Sector

Pharmaceuticals & Biotechnology

54.1% of portfolio

📋 What Happened This Month Among existing holdings, Fortis Healthcare Limited saw the biggest increase — now at 3.11% of the portfolio. Lupin Limited was trimmed the most, now at 3.97%. Sun Pharmaceutical Industries Limited remains the top holding with Pharmaceuticals & Biotechnology the dominant sector at 54.1%. ↓ Scroll down for full holdings, sector allocation and month-on-month changes in detail.

NAV Performance

1 year history · Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Plan - Growth

+1.53%

+3.47%

+4.69%

+15.15%

Latest NAV

₹22.48

04 Jun 2026

52W High

₹22.91

-2% from High

52W Low

₹18.34

+23% from Low

Calendar Year Returns

Jan 1 to Dec 31 each year. Simple point-to-point — not CAGR.

2025

+5.5%

2024

+29.6%

2023

+25.1%

2022

-4.8%

2021

+18.8%

Rolling Returns

Performance across every possible investment start date.

1Y Rolling Avg

15.5%

+ve in 79% windows

50.9% / -10.6%

3Y Rolling Avg

17.9% p.a.

+ve in 100% windows

25.4% / 13.4%

5Y Rolling Avg

14.9% p.a.

+ve in 100% windows

17.0% / 13.5%

Crisis Period Behaviour

"Pre-inception" = fund didn't exist during that period.

2024–25 Tariff

-12.2%

Rec: Oct 2025 (9 mo)

COVID-19 Crash

Pre-inception

Rec: N/A

2022 Rate Hike

-14.3%

Rec: Jun 2023 (1yr 5mo)

2018 IL&FS

Pre-inception

Rec: N/A

Risk Ratios

3 years daily NAV · Risk-free rate 6.5% p.a. What do these mean? →

Sharpe Ratio (3Y)

1.50

Return per unit of risk. >1 is good.

Sortino Ratio (3Y)

2.22

Penalises downside volatility only.

Std Deviation (3Y)

11.4%

Lower = more consistent returns.

NAV Chart ₹22.48 04 Jun 2026

Simple Moving Avg: Click to draw · click again to remove

Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Plan - Growth

Chart shows indexed performance (base = 100). Actual NAV: ₹22.48

Sector Shift Industry allocation month-over-month

Feb 2026 → Mar 2026

Sector	Prev	Curr ▼	Delta
Pharmaceuticals & Biotechnology	51.5%	53.0%	▲ +1.4%
Healthcare Services	17.6%	16.1%	▼ -1.5%

Mar 2026 → Apr 2026

Sector	Prev	Curr ▼	Delta
Pharmaceuticals & Biotechnology	53.0%	54.1%	▲ +1.2%
Healthcare Services	16.1%	16.7%	▲ +0.6%

↑

Biggest Add

Fortis Healthcare Limited

+0.34% · now 3.11%

↓

Biggest Trim

Lupin Limited

-0.16% · now 3.97%

What Changed?

Comparing Mar 2026 → Apr 2026

Mar 2026 → Apr 2026

↑ 16 Increased ↓ 7 Decreased

#	Stock	Sector	Mar 2026	Apr 2026	Change
1	Fortis Healthcare Limited ₹5.33 Cr	Healthcare Services	2.77%	3.11%	+0.34%
2	Glenmark Pharmaceuticals Limited ₹4.40 Cr	Pharmaceuticals & Biotechnology	2.27%	2.56%	+0.29%
3	Divi's Laboratories Limited ₹9.14 Cr	Pharmaceuticals & Biotechnology	5.08%	5.33%	+0.25%
4	Cipla Limited ₹8.71 Cr	Pharmaceuticals & Biotechnology	4.84%	5.08%	+0.24%
5	Laurus Labs Limited ₹4.55 Cr	Pharmaceuticals & Biotechnology	2.44%	2.65%	+0.21%
6	Mankind Pharma Limited ₹3.27 Cr	Pharmaceuticals & Biotechnology	1.72%	1.91%	+0.19%
7	Sun Pharmaceutical Industries Limited ₹20.42 Cr	Pharmaceuticals & Biotechnology	11.73%	11.90%	+0.17%
8	Dr. Reddy's Laboratories Limited ₹8.45 Cr	Pharmaceuticals & Biotechnology	4.76%	4.92%	+0.16%
9	Aurobindo Pharma Limited ₹4.27 Cr	Pharmaceuticals & Biotechnology	2.37%	2.49%	+0.12%
10	Aster DM Healthcare Limited ₹1.92 Cr	Healthcare Services	1.05%	1.12%	+0.07%
11	Global Health Limited ₹1.06 Cr	Healthcare Services	0.55%	0.62%	+0.07%
12	Apollo Hospitals Enterprise Limited ₹9.69 Cr	Healthcare Services	5.59%	5.65%	+0.06%
13	Narayana Hrudayalaya Limited ₹1.48 Cr	Healthcare Services	0.82%	0.86%	+0.04%
14	JB Chemicals & Pharmaceuticals Limited ₹2.07 Cr	Pharmaceuticals & Biotechnology	1.19%	1.21%	+0.02%
15	Gland Pharma Limited ₹1.53 Cr	Pharmaceuticals & Biotechnology	0.87%	0.89%	+0.02%
16	Emcure Pharmaceuticals Limited ₹56.22 L	Pharmaceuticals & Biotechnology	0.31%	0.33%	+0.02%

#	Stock	Sector	Mar 2026	Apr 2026	Change
1	Lupin Limited ₹6.82 Cr	Pharmaceuticals & Biotechnology	4.13%	3.97%	-0.16%
2	Torrent Pharmaceuticals Limited ₹5.83 Cr	Pharmaceuticals & Biotechnology	3.55%	3.40%	-0.15%
3	IPCA Laboratories Limited ₹2.51 Cr	Pharmaceuticals & Biotechnology	1.53%	1.46%	-0.07%
4	Biocon Limited ₹2.55 Cr	Pharmaceuticals & Biotechnology	1.55%	1.49%	-0.06%
5	Ajanta Pharma Limited ₹1.45 Cr	Pharmaceuticals & Biotechnology	0.89%	0.85%	-0.04%
6	Alkem Laboratories Limited ₹3.04 Cr	Pharmaceuticals & Biotechnology	1.79%	1.77%	-0.02%
7	GlaxoSmithKline Pharmaceuticals Limited ₹1.16 Cr	Pharmaceuticals & Biotechnology	0.70%	0.68%	-0.02%

Full Portfolio

25 stocks — Apr 2026

#	Stock	Sector	Weight & Value
1	Sun Pharmaceutical Industries Limited ₹20.42 Cr	Pharmaceuticals & Biotechnology	11.90%
2	Apollo Hospitals Enterprise Limited ₹9.69 Cr	Healthcare Services	5.65%
3	Divi's Laboratories Limited ₹9.14 Cr	Pharmaceuticals & Biotechnology	5.33%
4	Max Healthcare Institute Limited ₹9.10 Cr	Healthcare Services	5.30%
5	Cipla Limited ₹8.71 Cr	Pharmaceuticals & Biotechnology	5.08%
6	Dr. Reddy's Laboratories Limited ₹8.45 Cr	Pharmaceuticals & Biotechnology	4.92%
7	Lupin Limited ₹6.82 Cr	Pharmaceuticals & Biotechnology	3.97%
8	Torrent Pharmaceuticals Limited ₹5.83 Cr	Pharmaceuticals & Biotechnology	3.40%
9	Fortis Healthcare Limited ₹5.33 Cr	Healthcare Services	3.11%
10	Laurus Labs Limited ₹4.55 Cr	Pharmaceuticals & Biotechnology	2.65%
11	Glenmark Pharmaceuticals Limited ₹4.40 Cr	Pharmaceuticals & Biotechnology	2.56%
12	Aurobindo Pharma Limited ₹4.27 Cr	Pharmaceuticals & Biotechnology	2.49%
13	Mankind Pharma Limited ₹3.27 Cr	Pharmaceuticals & Biotechnology	1.91%
14	Alkem Laboratories Limited ₹3.04 Cr	Pharmaceuticals & Biotechnology	1.77%
15	Biocon Limited ₹2.55 Cr	Pharmaceuticals & Biotechnology	1.49%
16	IPCA Laboratories Limited ₹2.51 Cr	Pharmaceuticals & Biotechnology	1.46%
17	Zydus Lifesciences Limited ₹2.11 Cr	Pharmaceuticals & Biotechnology	1.23%
18	JB Chemicals & Pharmaceuticals Limited ₹2.07 Cr	Pharmaceuticals & Biotechnology	1.21%
19	Aster DM Healthcare Limited ₹1.92 Cr	Healthcare Services	1.12%
20	Gland Pharma Limited ₹1.53 Cr	Pharmaceuticals & Biotechnology	0.89%
21	Narayana Hrudayalaya Limited ₹1.48 Cr	Healthcare Services	0.86%
22	Ajanta Pharma Limited ₹1.45 Cr	Pharmaceuticals & Biotechnology	0.85%
23	GlaxoSmithKline Pharmaceuticals Limited ₹1.16 Cr	Pharmaceuticals & Biotechnology	0.68%
24	Global Health Limited ₹1.06 Cr	Healthcare Services	0.62%
25	Emcure Pharmaceuticals Limited ₹56.22 L	Pharmaceuticals & Biotechnology	0.33%